Skip to main content
. 2012 Apr;32(8):1483–1495. doi: 10.1128/MCB.05245-11

Fig 4.

Fig 4

Defective ERα- and PRβ-driven transcriptional activation in Med1+/− Med24+/− MEFs. (A) ERα-driven transcriptional activation is mildly attenuated in Med1−/− Med24+/+ MEFs and profoundly attenuated in Med1+/− Med24+/− MEFs. Values (means ± SD from a representative experiment performed in triplicate) are plotted as fold increase against the value of Med1+/+ Med24+/+ MEFs without ligand (A to C). The ligands used are 10−8 M E2, 10−7 M progesterone, and 10−7 M 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] (A to C). (B) PRβ-driven transcriptional activation is attenuated profoundly in Med1+/− Med24+/− MEFs. (C) Gal-VDR-driven transcription is attenuated in Med1−/− Med24+/+ MEFs but not affected in Med1+/− Med24+/− MEFs. (D) Gal-VP16-driven transcription is not affected in Med1+/− Med24+/− MEFs. Values (means ± SD from a representative experiment performed in triplicate) are plotted as fold increase against the value of Med1+/+ Med24+/+ MEFs without Gal4-VP16.